Paeds SAQs · growth-development-and-behaviour
Behavioural assessment and functional analysis — formative SAQs
Two formative SAQs on ABC functional assessment, four functions, PBS/FCT and limited medication after formulation.
On this page & tools
Target exams
SAQ 1 — Escape-maintained aggression and assessment method (10 marks)
A 7-year-old with limited speech and autism hits support workers during showering about four times weekly. Staff want risperidone increased. No dental or medical review is documented. ABC notes show hits at demand onset and stop when showering is abandoned. [1] [2] [10]
Questions
- Define challenging behaviour and distinguish it from a psychiatric diagnosis. (2 marks) [10]
- Outline a paediatric functional assessment for this presentation, including the likely primary function. (4 marks) [1] [2]
- State three immediate non-drug actions before any medication change. (4 marks) [4] [5] [10]
Model answer
Definition (2). Challenging behaviour describes intensity, frequency or duration that risks safety or seriously limits ordinary life. It is not itself a DSM/ICD diagnosis. Psychiatric disorders need their own criteria and may coexist. [10]
Assessment and function (4). Operationalise hits (topography, rate, intensity, context). Multi-informant history and multi-setting ABC charts. Medical/pain screen (dental, ENT, constipation, skin, sleep, seizures, medication adverse effects). Communication and sensory assessment. Hypothesise escape/avoidance of personal-care demand (and possible sensory aversion) because behaviour starts at demand and ends when the demand is removed. Consider experimental FA only via specialist teams if needed. [1] [2] [10]
Non-drug actions (4). Do not escalate risperidone by default. Complete medical/pain review. Redesign personal care (predictability, shorter steps, preferred sequence, sensory adaptations). Teach functional communication for “stop/help/break” and honour it while building tolerance. Active parent/carer training with practice (Bearss-type principle). Write a PBS plan with data review and least-restrictive reactive strategies. [4] [5] [10]
SAQ 2 — Medication thresholds and evidence (10 marks)
A registrar says “Tyrer means never use antipsychotics in children” and also says “RUPP means start risperidone first for any autism behaviour.” [6] [8]
Questions
- Correct both misunderstandings with the trial principles. (4 marks) [6] [8]
- List monitoring priorities if risperidone is used for severe irritability after formulation. (3 marks) [6] [10]
- Name four classic maintaining functions of problem behaviour. (3 marks) [2]
Model answer
Trials (4). Tyrer 2008: in adults with intellectual disability, risperidone and haloperidol were not superior to placebo for aggressive challenging behaviour — so antipsychotics are not routine first-line for CB as a class, especially without formulation. RUPP: risperidone reduced serious behavioural problems/irritability in children with autism in a controlled trial — after, not instead of, behavioural and environmental care; it does not treat core autism social deficits and is not “any behaviour, first tablet.” [6] [8] [10]
Monitoring (3). Weight/BMI, metabolic panel (glucose/lipids), extrapyramidal symptoms, prolactin-related symptoms/signs, sedation; named target behaviour, lowest effective dose, time-limited goals and review date. [6] [10]
Functions (3). Attention; escape/avoidance; tangible access; automatic/sensory. [2]
References
- [1]Iwata BA, Dorsey MF, Slifer KJ, Bauman KE, Richman GS Toward a functional analysis of self-injury. Journal of applied behavior analysis, 1994.PMID 8063622
- [2]Beavers GA, Iwata BA, Lerman DC Thirty years of research on the functional analysis of problem behavior. Journal of applied behavior analysis, 2013.PMID 24114081
- [4]Ghaemmaghami M, Hanley GP, Jessel J Functional communication training: From efficacy to effectiveness. Journal of applied behavior analysis, 2021.PMID 32929757
- [5]Bearss K, Johnson C, Smith T, et al. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial. JAMA, 2015.PMID 25898050
- [6]McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. The New England journal of medicine, 2002.PMID 12151468
- [8]Tyrer P, Oliver-Africano PC, Ahmed Z, et al. Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. Lancet, 2008.PMID 18177776
- [10]Hyman SL, Levy SE, Myers SM Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Pediatrics, 2020.PMID 31843864